Blosozumab

Tax included
Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis.
HY-P99186

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
1132758-87-2